Detalhe da pesquisa
1.
Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma.
BMC Genomics
; 24(1): 221, 2023 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37106442
2.
Global burdens of nasopharyngeal carcinoma in children and young adults and predictions to 2040.
Oral Oncol
; 155: 106891, 2024 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38878356
3.
Individualized Concurrent Chemotherapy for Patients with Stage III-IVa Nasopharyngeal Carcinoma Receiving Neoadjuvant Chemotherapy Combined with Definitive Intensity-Modulated Radiotherapy.
Cancer Res Treat
; 55(4): 1113-1122, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37170497
4.
Plasma Epstein-Barr viral DNA load after completion of two cycles of induction chemotherapy predicts outcomes for patients with advanced-stage nasopharyngeal carcinoma.
Oral Oncol
; 131: 105972, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35728415